Clinical characteristics and somatic burden of patients with mucopolysaccharidosis II with or without neurological involvement: An analysis from the Hunter Outcome Survey

Approximately two-thirds of patients with mucopolysaccharidosis II (MPS II; Hunter syndrome) have neuronopathic disease, with central nervous system involvement; one-third have non-neuronopathic disease. This analysis of data from the Hunter Outcome Survey (HOS) compared the clinical manifestations...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Heather, Harmatz, Paul, Botha, Jaco, Audi, Jennifer, Link, Bianca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694755/
http://dx.doi.org/10.1016/j.ymgmr.2023.101005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694755/
http://dx.doi.org/10.1016/j.ymgmr.2023.101005

Ejemplares similares